COMBINATION OF HMG-COA REDUCTASE INHIBITORS WITH PHOSPHODIESTERASE 4 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY PULMONARY DISEASES

• 收藏
• 分享

专利权人:

发明人:

볼린 스테판-루츠,볼센 안드레아,브라운 클레멘스,막스 데젠하르트

申请号：

KR1020097001868

公开号：

KR1014333940000B1

申请日:

2007.07.03

申请国别(地区):

KR

年份:

2014

代理人:

摘要：

The invention relates to the combined use of a PDE4 inhibitor with a HMG-CoA reductase inhibitor for the preventive and curative treatment of an inflammatory pulmonary disease, wherein the PDE4 inhibitor is selected from the group consisting of ROFLUMILAST, a pharmaceutically acceptable salt of ROFLUMILAST, ROFLUMILAST-N-oxide and a pharmaceutically acceptable salt of ROFLUMILAST-N-oxide, the HMG-CoA reductase inhibitor is ROSUVASTATIN or a pharmaceutically acceptable salt thereof.본 발명은 염증성 폐질환의 예방적 또는 치료적 처치를 위하여 HMG-CoA 리덕타제 억제제와 PDE4 억제제를 병용하여 사용하는 것에 관한 것이다.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/